Expression patterns of the tumor suppressor PDCD4 and correlation with β-catenin expression in gastric cancers

Oncology Reports

Volumn 26, Issue 6, 2011, Pages 1385-1392

  Kakimoto, Takashi ^a,c   Shiraishi, Ryosuke ^a   Iwakiri, Ryuichi ^a   Fujimoto, Kazuma ^a   Takahashi, Hirokazu ^a   Hamajima, Hiroshi ^a   Mizuta, Toshihiko ^a   Ideguchi, Hiroyuki ^b   Toda, Shuji ^b   Kitajima, Yoshihiko ^b   Ozaki, Iwata ^a   Matsuhashi, Sachiko ^a  

^a SAGA UNIVERSITY   (Japan)

^b SAGA UNIVERSITY   (Japan)

^c NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

catenin; Gastric carcinoma; Programmed cell death 4

Indexed keywords

BETA CATENIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; COLON CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE LOCATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGRAMMED CELL DEATH 4 GENE; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNET RING CARCINOMA; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; BETA CATENIN; CELL LINE, TUMOR; CELL MEMBRANE; CELL NUCLEUS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; RNA-BINDING PROTEINS; STOMACH NEOPLASMS;

EID: 80053529290     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1450     Document Type: Article

References (49)

1. Matsuhashi S, Yoshinaga H, Yatsuki H, Tsugita A and Hori K: Isolation of a novel gene from a human cell line with Pr-28 MAb which recognizes a nuclear antigen involved in the cell cycle. Res Commun Biochem Cell Mol Biol 1: 109-120, 1997.
2. Yoshinaga H, Matsuhashi S, Fujiyama C and Masaki Z: Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody. Pathol Int 49: 1067-1077, 1999. (Pubitemid 30193505)
3. Soejima H, Miyoshi O, Yoshinaga H, Masaki Z, Ozaki O, Kajihara S, Niikawa N, Matsuhashi S and Mukai T: Assignment of the programmed cell death 4 gene (PDCD4) to human chromosome band 10q24 by in situ hybridization. Cytogenet Cell Genet 87: 113-114, 1999. (Pubitemid 30021050)
4. Shibahara K, Asano M, Ishida Y, Aoki T, Koike T and Honjo T: Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 166: 297-301, 1995.
5. Onishi Y, Hashimoto S and Kizaki H: Cloning of the TIS gene suppressed by topoisomerase inhibitors. Gene 215: 453-459, 1998. (Pubitemid 28382949)
6. Schlichter U, Burk O, Worpenberg S and Klempnauer KH: The chicken Pdcd4 gene is regulated by v-Myb. Oncogene 20: 231-239, 2001. (Pubitemid 32150268)
7. Schlichter U, Kattmann D, Appl H, Miethe J, Brehmer-Fastnacht A and Klempnauer KH: Identification of the myb-inducible promoter of the chicken Pdcd4 gene. Biochem Biophys Acta 1520: 99-104, 2001. (Pubitemid 32721941)
8. Goke A, Goke R, Knolle A, Trusheim H, Schmidt H, Wilmen A, Carmody R, Goke B and Chen YH: DUG is a novel homologue of translation initiation factor 4G that binds eIF4A. Biochem Biophys Res Commun: 297: 78-82, 2002.
9. Azzoni L, Zatsepnia O, Abebe B, Bennett IM, Kanakaraj P and Perussia BJ: Differential transcriptional regulation of CD161 and a novel gene, 197/15a by IL-2, IL-15 and IL-12 in NK and T cells. J Immunol 161: 3493-3500, 1998.
10. Afonia O, Juste D, Das S, Matsuhashi S and Samuels HH: Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene 23: 8135-8145, 2004. (Pubitemid 39531854)
11. Schmid T, Jansen AP, Baker AR, Hegamyer G, Hagen JP and Colburn NH: Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. Cancer Res 68: 1254-1260, 2008. (Pubitemid 351346830)
12. Nakashima M, Hamajima H, Xia J, Iwane S, Kawaguchi Y, Eguchi Y, Mizuta T, Fujimoto K, Ozaki I and Matsuhashi S: Regulation of tumor suppressor PDCD4 by novel protein kinase C isoforms. Biochim Biophys Acta 1803: 1020-1027, 2010.
13. Zhang H, Ozaki I, Mizuta T, Hamajima H, Yasutake T, Eguchi Y, Ideguchi H, Yamamoto K and Matsuhashi S: Involvement of programmed cell death 4 in transforming growth factor-β1-induced apoptosis in human hepatocellular carcinoma. Oncogene 25: 6101-6112, 2006. (Pubitemid 44562408)
14. Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE and Pagano M: S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314: 467-471, 2006. (Pubitemid 44628968)
15. Matsuhashi S, Narisawa Y, Ozaki I and Mizuta T: Expression patterns of programmed cell death 4 protein in normal skin and some representative skin lesions. Exp Dermatol 16: 179-184, 2007. (Pubitemid 46242959)
16. Chen Y, Knosel T, Kristiansen G, Pietas A, Garber ME, Matsuhashi S, Ozaki I and Petersen I: Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol 200: 640-646, 2003. (Pubitemid 36987314)
17. Ma G, Guo KJ, Zhang H, Ozaki I, Matsuhashi S, Zheng XY and Dong M: Expression of programmed cell death 4 and its clinicopathological significance in human pancreatic cancer. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 27: 597-600, 2005.
18. Lee S, Bang S, Song K and Lee I: Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon. Oncol Rep 16: 747-754, 2006.
19. Wen YH, Shi X, Chiriboga L, Matsuhashi S, Yee H and Afonia O: Alterations in the expression of PDCD4 in ductal carcinoma of the breast. Oncol Rep 18: 1387-1393, 2007.
20. Gao F, Zhang P, Zhou C, Li J, Wang Q, Zhu F, Ma C, Sun W and Zhang L: Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma. Oncol Rep 17: 123-128, 2007.
21. Allgayer H: PDCD4, a colon cancer prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol 73: 185-191, 2010.
22. Young MR, Santhanam AN, Yoshikawa N and Colburn NH: Have tumor suppressor PDCD4 and its counteragent oncogenic miR-21 gone rogue? Mol Interv 10: 76-79, 2010.
23. Aravind L and Koonin EV: Eukaryote-specific domains in translation initiation factors: inplications for translation regulation and evolution of the translation system. Genome Res 10: 1172-1184, 2000.
24. Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S, Lockett SJ, Sonenberg N and Colburn NH: The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 23: 26-37, 2003. (Pubitemid 36008498)
25. Yang HS, Cho MH, Zakowicz H, Hegamyer G, Sonenberg N and Colburn NH: A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol Cell Biol 24: 3894-3906, 2004. (Pubitemid 38496167)
26. LaRonde-LeBlanc N, Santhanam AN, Baker AR, Wlodawer A and Colburn NH: Structural basis for inhibition of translation by the tumor suppressor Pdcd4. Mol Cell Biol 27: 147-156, 2007. (Pubitemid 46013240)
27. Suzuki C, Garces RG, Edmonds KA, Hiller S, Hyberts SG, Marintchev A and Wagner G: PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains. Proc Natl Acad Sci USA 105: 3274-3279, 2008. (Pubitemid 351723543)
28. Cmarik JL, Min H, Hegamyer G, Zhan S, Kulesz-Martin M, Yoshinaga H, Matsuhashi S and Colburn NH: Differentially expressed protein Pdcd4 inhibits tumor pormoter-induced neoplastic transformation. Proc Natl Acad Sci USA 96: 14037-14042, 1999.
29. Yang HS, Jansen AP, Nair R, Shibahara K, Verma AK, Cmarik JL and Colburn NH: A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene 20: 669-676, 2001. (Pubitemid 32179335)
30. Yang HS, Knies JL, Stark C and Colburn NH: Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene 22: 3712-3720, 2003. (Pubitemid 36760733)
31. Bitomsky N, Bohm M and Klempnauer KH: Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene 23: 7484-7493, 2004. (Pubitemid 39389690)
32. Yang HS, Matthews CP, Clair T, Wang Q, Baker AR, Li CC, Tan TH and Colburn NH: Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol 26: 1297-1306, 2006. (Pubitemid 43202557)
33. Jansen AP, Camalier CE and Colburn NH: Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis, Cancer Res 65: 6034-6041, 2005. (Pubitemid 40994387)
34. Hilliard A, Hilliard B, Zheng SJ, Sun H, Miwa T, Song W, Goke R and Chen YH: Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4. J Immunol 177: 8095-8102, 2006. (Pubitemid 44846328)
35. Wang Q, Sun Z and Yang HS: Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells. Oncogene 27: 1527-1535, 2008. (Pubitemid 351347877)
36. Wang Q, Sun ZX, Allgayer H and Yang HS: Downregulation of E-cadherin is an essential event in activating β-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells. Oncogene 29: 128-138, 2010.
37. Santhanam AN, Baker AR, Hegamyer G, Kirschmann DA and Colburn NH: Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion. Oncogene 29: 3921-3932, 2010.
38. Motoyama K, Inoue H, Mimori K, Tanaka F, Kojima K, Uetake H, Sugihara K and Mori M: Clinocopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer. Int J Oncol 36: 1089-1095, 2010.
39. Yanagihara K, Tanaka H, Takigahira M, Ino Y, Yamaguchi Y, Toge T, Sugano K and Hirohashi S: Establishment of two cell lines from human gastric scirrhous carcinoma that posseess the potential to metastasize spontaneously in nude mice. Cancer Sci 95: 575-582, 2004. (Pubitemid 39089638)
40. Grabsch H, Takeno S, Noguchi T, Hommel G, Gabbert HE and Mueller W: Different patterns of β-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome. Histopathology 39: 141-149, 2001. (Pubitemid 34225040)
41. Fassan M, Pizzi M, Giacomelli L, Mescoli C, Ludwig K, Pucciarelli S and Rugge M: PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis. Virchows Arch 458: 413-419, 2011.
42. Gao F, Wang X, Zhu F, Wang Q, Zhang X, Guo C, Zhou C, Ma C, Sun W, Zhang Y, Chen YH and Zhang L: PDCD4 gene silencing in gliomas is associated with 5′CpG island methylation and unfavourable prognosis. J Cell Mol Med 13: 4257-4267, 2009.
43. Gregorieff A and Clevers H: Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev 19: 877-890, 2005. (Pubitemid 40548056)
44. Zheng HC, Xu XY, Xia P, Yu M, Takahashi H and Takano Y: Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas. Hum Pathol 41: 1255-1264, 2010.
45. Mishra P, Senthivinayagam S, Rana A and Rana B: Glycogen synthase kinase-3beta regulates Snail and beta-catenin during gastrin-induced migration of gastric cancer cells. J Mol Signal 5: 9, 2010.
46. Joo YE, Rew JS, Choi SK, Bom HS, Park CS and Kim SJ: Expression of E-cadherin and catenins in early gastric cancer. J Clin Gastroenterol 35: 35-42, 2002.
47. Czyzewska J, Guzinska-Ustymowicz K, Ustymowicz M, Pryczynicz A and Kemona A: The expression of E-cadherin-catenin complex in patients with advanced gastric cancer: role in formation of metastasis. Folia Histchem Cytobiol 48: 37-45, 2010.
48. Wang W, Zhao J, Wang H, Sun Y, Peng Z, Zhou G, Fan L, Wang X, Yang S, Wang R and Fang D: Programmed cell death 4 (PDCD4) mediates the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by down-regulation of FLIP expression. Exp Cell Res 316: 2456-2464, 2010.
49. Wang WQ, Zhang H, Wang HB, Sun YG, Peng ZH, Zhou G, Yang SM, Wang RO and Fang DC: Programmed cell death4 (PDCD4) enhances the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by inhibiting the PI3K/Akt signaling pathway. Mol Diagn Ther 14: 155-161, 2010.